FDA and the role of e-cigarettes in harm reduction

Author： Wilcox Neil L.   Kovacevic Patricia I.  

Publisher： Emerald Group Publishing Ltd

ISSN： 1745-9265

Source： Drugs and Alcohol Today, Vol.13, Iss.2, 2013-06, pp. : 79-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regulating E-cigarettes: A rule proposed by the FDA aims to extend authority to E-cigarettes, other tobacco products

By Printz Carrie  

Cancer, Vol. 120, Iss. 14, 2014-07 ,pp. : 2069-2071

Blackwell Publishing

Access to resources Recommend Favorite

E‐Cigarettes: Policy Options and Legal Issues Amidst Uncertainty

By  

THE JOURNAL OF LAW, MEDICINE & ETHICS, Vol. 43, Iss. s1, 2015-03 ,pp. : 23-26

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Ethics of Harm Reduction

By Kleinig John  

Substance Use & Misuse, Vol. 43, Iss. 1, 2008-01 ,pp. : 1-16

Informa Healthcare

Access to resources Recommend Favorite

Maximising the effectiveness of harm reduction programmes

By Wood E.   Spittal P.M.  

The International Journal of Drug Policy, Vol. 14, Iss. 4, 2003-08 ,pp. : 291-292

Elsevier

Access to resources Recommend Favorite

Tobacco harm reduction: opportunity and opposition

By Phillips Carl V.   Rodu Brad  

Drugs and Alcohol Today, Vol. 13, Iss. 2, 2013-06 ,pp. : 73-78

Emerald Group Publishing Ltd

Access to resources Recommend Favorite